Introduction
Calcium phosphate bioceramics have been successfully employed as bone repairing and substituting materials in many dental and orthopedic applications due to their excellent biocompatibility and osteoconductivity. Commercial hydroxyapatite (HA), β-tricalcium phosphate (β-TCP), and biphasic calcium phosphate (BCP) ceramics are currently available in the form of granules and blocks manufactured by sintering of powders with the adequate stoichiometry. However, the customary manufacturing process of these ceramics brings about limitations in terms of the size and shape of the implants [1] [2] [3] .
To overcome this handicap it has been recently proposed a new calcium phosphate biomaterial composed by β-TCP, calcium deficient hydroxyapatite (CDHA), and octacalcium phosphate (OCP), which can be obtained in practically any desired shape and size [4] . The new biomaterial is obtained by hydrothermal processing of conventional dicalcium phosphate dihydrate (DCPD) cement and has been proposed to manufacture tailored bone implants for cranio-maxillo-facial surgery [4] . The new material is composed of 14 wt.-% CDHA, 39 wt.-% OCP, and 47 wt.-% TCP [5] [6] , and it has shown apatite forming ability by soaking in SBF, which make it a promising scaffold for in situ bone regeneration procedures [6] . Thus, the aim of this study was to investigate its biological behavior by in vitro indirect and direct cytotoxicity, cell adhesion and proliferation tests, and by in vivo subcutaneous and bone implantation in rats.
Materials and Methods
Materials. The material was shaped into disks (12 mm diameter x 1 mm height) and cylinders (1 mm diameter x 4 mm length) as described elsewhere [4, 6] . Disks and cylinders were sterilized with ethylene oxide and used for in vitro and in vivo tests, respectively. In vitro tests. Cultures of human primary fibroblastic cells (HPFC) were exposed to extracts made from the material for 1, 2, 7, 14 and 21 days, and cell viability was evaluated by the MTT [7] method and by direct observation under the light transmission microscope (LTM) after dying (Eosin G-Thiazine). Cell adhesion and proliferation were assessed by culturing HPFC on the material for 1, 4, 7, 14 and 21 days, and measuring the relative amount of viable cells adhered onto its surface by the Alamar Blue (AB) test [7] , and the relative amount of lysed (non-viable) cells by the LDH-INT [8] method. Cell adhesion and morphology were studied by scanning electron microscopy (SEM) as well. Student-t test (2-tails, unpaired, α=0.05) was used to detect significant differences between the results of MTT, AB, and LDH-INT assays obtained for the material and the (-) control for each period of time. In vivo studies. Cylinders were implanted subcutaneously in the dorsal region and the anterior tibia of adult male Rattus Norvevicus Holtzman. Void surgical sites were employed as control. After 7, 30, and 120 days animals were sacrificed and the blocks of tissue containing the implants were removed, fixed, dehydrated, decalcified (bone sites), and included in paraffin. Serial sections (6 µm) were plated on glass slides, dyed with HE and examined under the LTM.
Results and Discussion
The results of the MTT assay ( Fig. 1 ) showed significant differences for all periods of extraction between the experimental scaffold and the (-) control. Even so, more than 70 % of cells survived (with regard to (-) control, Thermanox ® , THX), which permits to consider the scaffold extracts as no ciytotoxic. However, slightly lower cell proliferation on the material than in the control was observed for all periods of time under LTM, but neither cell death caused by necrosis nor apoptosis were noticed, as showed in Fig. 2 for the 14 days period.
The findings from AB assay indicated significant differences between the scaffold and the (-) control at every period of time as well (Fig. 1) . They revealed a good initial (1 day) cell adhesion onto the scaffold surface, but the adhered cells practically do not proliferate (2 and 7 days) and become detached (14 and 21 days).
The results of the LDH test (Fig. 1) showed lesser cell lysis than on the (-) control but probably due to lower initial cell adhesion on the scaffold surface than on the (-) control. The SEM micrographs (Fig. 3) confirmed lesser cell adhesion and proliferation on the material than on the control but those cells on the material surface appeared well extended and plated, intimately adhered to the substrate and displayed normal morphology.
The results of the in vitro studies demonstrated that the scaffold composed by CDHA, OCP, and β-TCP is no cytotoxic and biocompatible. The lower cell proliferation observed with regard to control may be attributed to surface roughness and remodeling that takes place in physiological medium [6] , which in certain degree may affect the normal rate of cell mitosis. Fig. 4a shows an implant site in tibia after 7 days. Some rest of material (arrow) remained after decalcification. A lot of osteocytes and capillary vessels (v) were disposed above the bone defect (*). The surrounding bone tissue showed normal appearance, partial repairing of the bone defect and no signs of inflammation were observed.
After 30 days (Fig. 4b ) the whole bone defect (arrows) was filled with new bone tissue with plenty of osteocytes and capillary vessels. None evidence of the bone defect remained after 120 days (Fig. 4c) , complete bone repairing and maturation was observed at the implant site.
Bone control sites evolved in comparable way and rates to implant sites. The biological response observed for implants in soft tissue (dorsal) was quite different. At 7 days (Figs. 4d and 4e) , the whole implant (Fig. 4d, *) still remained in the surgical cavity
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surrounded by normal conjunctive tissue. However, dilated and congested capillary vessels (Fig. 4e , white arrow) suggested a mild inflammatory response. At day 30 th (Figs. 4f and 4g ), a fibrous capsule (black arrows) enclosed the partially surface degraded implant (*). The capsule was rich in collagen fibers, fibroblasts, and mononuclear chronic inflammatory cells like macrophagues, lymphocytes and giant cells (gc).
The remaining material was removed from blocks corresponding to the 120 days period before serial cutting. At this period (Figs. 4h and 4i ) well organized connective tissue was observed around the implant site (black arrows) without any signs of inflammatory cells. No evidences for ectopic osteogenesis were detected at any implantation period.
Dorsal control sites exhibited a very mild inflammatory response at the 7 days period that disappeared after 30 days, with complete and normal healing of the surgical wound. 
Conclusions
The results of the in vitro studies showed that the CDHA/OCP/β-TCP scaffold is no cytotoxic and biocompatible. The lower cell proliferation observed with regard to (-) control may be attributed to surface roughness and reactivity, which, in certain degree, hinders the normal reproduction of cells adhered onto its surface. On the other hand, in vivo results showed that the scaffold is biocompatible, biodegradable and bioactive in bone tissue, but only biocompatible and partially biodegradable in soft tissue. 
